Prelude Capital Management, LLC Fulgent Genetics, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $8,374 - $17,219	-942 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.75 - $19.75 $43,908 - $128,473	-6,505 Reduced 87.35%	942 $10,000
Q4 2019 Feb 14, 2020	SELL	$9.29 - $15.82 $48,168 - $82,026	-5,185 Reduced 41.05%	7,447 $96,000
Q3 2019 Nov 14, 2019	BUY	$5.96 - $12.81 $75,286 - $161,815	12,632 New	12,632 $131,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.